Kunihiko Ito joined ONO PHARMA USA, INC. as President and CEO in April 2020. As an Officer of ONO PHARMACEUTICAL CO., LTD. and the President and Chief Executive Officer of ONO PHARMA USA, INC., Kunihiko is responsible for leading the U.S. organization in planning, directing, and executing all business objectives to drive corporate growth. 

Kunihiko has over 25 years of extensive experience within ONO including sales, licensing, business development, corporate development, new launches, the start-up of the South Korea & Taiwan subsidiaries and as Head of Overseas Strategy and Head of International Business in Headquarters. He also has held over 15 years of overseas assignments including in the UK, Taiwan and in South Korea as Branch Manager and President/CEO. 

Kunihiko holds an M.B.A. from the Graduate School of Management, GLOBIS University, and two Certificates from Duke University Fuqua Business School Executive Education (Drug Development, Reimbursement & Regulation) and Columbia Business School Executive Education Finance Program (M&A).